Sera Prognostics (SERA) Interest & Investment Income (2020 - 2026)
Sera Prognostics (SERA) posted Interest & Investment Income of $26000.0 for Q1 2026, down 99.34% on a QoQ basis from $4.0 million in Q4 2025, and down 97.18% year-over-year from $921000.0 in Q1 2025.
Sera Prognostics (SERA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Sera Prognostics' Interest & Investment Income history runs 6 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 97.18% year-over-year to $26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 37.86% YoY) and the FY2025 annual result came in at $4.3 million, up 54.82% from the prior year.
- Interest & Investment Income was $26000.0 for Q1 2026 at Sera Prognostics, down from $4.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.0 million in Q4 2025 and bottomed at $26000.0 in Q1 2026.
- A 4-year average of $810090.9 and a median of $671000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income soared 488.26% — and 2026, when it plunged 97.18%.
- Sera Prognostics' Interest & Investment Income stood at $927000.0 in 2023, then retreated by 27.4% to $673000.0 in 2024, then surged by 488.26% to $4.0 million in 2025, then sank by 99.34% to $26000.0 in 2026.
- Business Quant data shows SERA's Interest & Investment Income at $26000.0 in Q1 2026, $4.0 million in Q4 2025, and $66000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 3.96 Mn |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 82,000.00 |
| Mar 31, 2025 | 921,000.00 |
| Dec 31, 2024 | 673,000.00 |
| Sep 30, 2024 | 733,000.00 |
| Jun 30, 2024 | 671,000.00 |
| Mar 31, 2024 | 339,000.00 |
| Dec 31, 2023 | 927,000.00 |
| Sep 30, 2023 | 514,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Jun 30, 2020 | 6,000.00 |